|
US2913454A
(en)
*
|
1956-11-23 |
1959-11-17 |
Schenley Ind Inc |
Certain cycloalkanotriazoles, process and intermediates
|
|
US3723442A
(en)
*
|
1970-12-31 |
1973-03-27 |
Yoshitomi Pharmaceutical |
3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
|
|
US3784551A
(en)
*
|
1971-07-08 |
1974-01-08 |
Yoshitomi Pharmaceutical |
2-oxo-1,4-dioxa-8-azaspiro (4.5) decanes and related compounds
|
|
US4350696A
(en)
*
|
1980-03-08 |
1982-09-21 |
Pfizer Inc. |
Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
|
|
AU557300B2
(en)
*
|
1982-03-16 |
1986-12-18 |
Farmitalia Carlo Erba S.P.A. |
Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
|
|
FR2557110B1
(fr)
*
|
1983-12-23 |
1989-11-24 |
Sandoz Sa |
Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
|
|
YU213587A
(en)
*
|
1986-11-28 |
1989-06-30 |
Orion Yhtymae Oy |
Process for obtaining new pharmacologic active cateholic derivatives
|
|
US5283352A
(en)
*
|
1986-11-28 |
1994-02-01 |
Orion-Yhtyma Oy |
Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
|
|
FI864875A0
(fi)
*
|
1986-11-28 |
1986-11-28 |
Orion Yhtymae Oy |
Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
|
|
US4851423A
(en)
*
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5750532A
(en)
*
|
1986-12-10 |
1998-05-12 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5272167A
(en)
*
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5225402A
(en)
*
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
GB8904174D0
(en)
*
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
|
US5169850A
(en)
*
|
1990-01-22 |
1992-12-08 |
American Cyanamid Company |
N-(dialkylamino)methylene)-substituted pyrazolo(1,5-a)-pyrimidine-3-carboxamides and N-(dialkylamino)methylene-substituted-4,5-dihydropyrazolo-(1,5-a)-pyrimidine-3-carboxamides
|
|
US5591892A
(en)
*
|
1990-02-12 |
1997-01-07 |
Center For Innovative Technology |
Allosteric modifiers of hemoglobin
|
|
US5432191A
(en)
*
|
1990-02-12 |
1995-07-11 |
The Center For Innovative Technology |
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5648375A
(en)
*
|
1990-02-12 |
1997-07-15 |
Virginia Commonwealth University |
Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers
|
|
US5731454A
(en)
*
|
1990-02-12 |
1998-03-24 |
Virginia Commonwealth University |
Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
US5290803A
(en)
*
|
1990-02-12 |
1994-03-01 |
The Center Of Innovative Technology |
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
|
|
US5677330A
(en)
*
|
1990-02-12 |
1997-10-14 |
The Center For Innovative Technology |
Medical uses of allosteric hemoglobin modifier compounds in patient care
|
|
US5382680A
(en)
*
|
1990-12-07 |
1995-01-17 |
The Center For Innovative Technology |
Allosteric hemoglobin modifier compounds
|
|
US5705521A
(en)
*
|
1990-02-12 |
1998-01-06 |
The Center For Innovative Technology |
Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
|
|
US5049695A
(en)
*
|
1990-02-12 |
1991-09-17 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers
|
|
US5122539A
(en)
*
|
1990-02-12 |
1992-06-16 |
Center For Innovative Technology |
Allosteric hemoglobin modifiers useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
|
|
US5872282A
(en)
*
|
1990-12-07 |
1999-02-16 |
Virginia Commonwealth University |
Allosteric modifiers of hemoglobin
|
|
FR2677984B1
(fr)
*
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5260325A
(en)
*
|
1991-08-19 |
1993-11-09 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking tertiary amides
|
|
US5258407A
(en)
*
|
1991-12-31 |
1993-11-02 |
Sterling Winthrop Inc. |
3,4-disubstituted phenols-immunomodulating agents
|
|
US5356904A
(en)
*
|
1992-10-07 |
1994-10-18 |
Merck & Co., Inc. |
Carbostyril oxytocin receptor antagonists
|
|
ATE236164T1
(de)
*
|
1992-12-04 |
2003-04-15 |
Janssen Pharmaceutica Nv |
Antiallergische triazolobenzazepinderivate
|
|
US5571813A
(en)
*
|
1993-06-10 |
1996-11-05 |
Beiersdorf-Lilly Gmbh |
Fused pyrimidine compounds and their use as pharmaceuticals
|
|
US5395846A
(en)
*
|
1993-06-25 |
1995-03-07 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Amino Bi- and tri-carbocyclic aklane bis-aryl squalene synthase inhibitors
|
|
FR2708608B1
(fr)
*
|
1993-07-30 |
1995-10-27 |
Sanofi Sa |
Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
|
|
PL181782B1
(pl)
*
|
1993-08-10 |
2001-09-28 |
Black James Foundation |
Nowe zwiazki i sposób wytwarzania nowych zwiazków PL
|
|
US5674879A
(en)
*
|
1993-09-24 |
1997-10-07 |
G.D. Searle & Co. |
Compositions including and methods of using conformationally restricted angiotensin II antagonist
|
|
US5426105A
(en)
*
|
1993-09-24 |
1995-06-20 |
G.D. Searle & Co. |
Conformationally restricted angiotensin II antagonists
|
|
TW279860B
(https=)
*
|
1993-11-12 |
1996-07-01 |
Ciba Geigy Ag |
|
|
GB9409150D0
(en)
*
|
1994-05-09 |
1994-06-29 |
Black James Foundation |
Cck and gastrin receptor ligands
|
|
US5795907A
(en)
*
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
|
WO1995032949A1
(en)
*
|
1994-05-27 |
1995-12-07 |
James Black Foundation Limited |
Gastrin and cck antagonists
|
|
CZ61098A3
(cs)
*
|
1995-08-30 |
1998-06-17 |
Bayer Aktiengesellschaft |
Amidy kyseliny acylaminosalicylové jako prostředky pro potírání škůdců, způsob jejich výroby a meziprodukty pro jejich výrobu
|
|
FR2741878B1
(fr)
*
|
1995-12-01 |
1998-01-09 |
Cird Galderma |
Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
|
|
TW359669B
(en)
*
|
1995-12-15 |
1999-06-01 |
Otsuka Pharma Co Ltd |
Benzazepine derivatives
|
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
|
NZ500590A
(en)
*
|
1997-04-22 |
2001-11-30 |
Cocensys Inc |
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
|
|
US6506783B1
(en)
*
|
1997-05-16 |
2003-01-14 |
The Procter & Gamble Company |
Cancer treatments and pharmaceutical compositions therefor
|
|
US6521641B1
(en)
*
|
1998-10-08 |
2003-02-18 |
Allergan, Inc. |
Male anti-fertility agents
|
|
US6541477B2
(en)
*
|
1999-08-27 |
2003-04-01 |
Scios, Inc. |
Inhibitors of p38-a kinase
|
|
US6586433B2
(en)
*
|
1999-09-23 |
2003-07-01 |
Pharmacia Corporation |
Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
SE0001899D0
(sv)
*
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US6482829B2
(en)
*
|
2000-06-08 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor
|
|
US7129242B2
(en)
*
|
2000-12-06 |
2006-10-31 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
|
|
US20050154202A1
(en)
*
|
2002-04-05 |
2005-07-14 |
Hagmann William K. |
Substituted aryl amides
|
|
AU2003250117B2
(en)
*
|
2002-07-29 |
2007-05-10 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
|
US7186735B2
(en)
*
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
|
EP1562925B1
(en)
*
|
2002-11-07 |
2007-01-03 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
WO2004056744A1
(en)
*
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
EP1603884A4
(en)
*
|
2003-02-28 |
2008-05-28 |
Encysive Pharmaceuticals Inc |
PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE AND NAPHTHALENE UROTENSIN II RECEPTOR ANTAGONISTS
|
|
US7320989B2
(en)
*
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
JP4564485B2
(ja)
*
|
2003-02-28 |
2010-10-20 |
帝人ファーマ株式会社 |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
US20060094699A1
(en)
*
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
|
US20070270408A1
(en)
*
|
2003-04-11 |
2007-11-22 |
Novo Nordisk A/S |
Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines
|
|
DE602004025220D1
(de)
*
|
2003-04-11 |
2010-03-11 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1,2,4-triazolen
|
|
US7501405B2
(en)
*
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
|
US7700583B2
(en)
*
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
|
ATE467616T1
(de)
*
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
|
US7915293B2
(en)
*
|
2003-05-30 |
2011-03-29 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
WO2005037199A2
(en)
*
|
2003-10-10 |
2005-04-28 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
US20050261302A1
(en)
*
|
2004-04-29 |
2005-11-24 |
Hoff Ethan D |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
|
|
WO2006016882A2
(en)
*
|
2004-07-08 |
2006-02-16 |
Ndsu Research Foundation |
Methods and materials for enhancing the effects of protein modulators
|
|
WO2006040329A1
(en)
*
|
2004-10-12 |
2006-04-20 |
Novo Nordisk A/S |
1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
JP5133702B2
(ja)
*
|
2005-01-05 |
2013-01-30 |
アボット・ラボラトリーズ |
１１−β−ヒドロキシステロイドデヒドロゲナーゼ１型酵素の阻害薬
|
|
BRPI0618051A2
(pt)
*
|
2005-11-01 |
2011-08-16 |
Transtech Pharma Inc |
uso farmacêutico de amidas substituìdas
|
|
KR20080076916A
(ko)
*
|
2005-11-01 |
2008-08-20 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
|
EP2007722A1
(en)
*
|
2006-03-21 |
2008-12-31 |
High Point Pharmaceuticals, LLC |
Adamantane derivatives for the treatment of the metabolic syndrome
|
|
KR20090014347A
(ko)
*
|
2006-04-07 |
2009-02-10 |
하이 포인트 파마슈티칼스, 엘엘씨 |
11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
JP2010519239A
(ja)
*
|
2007-02-23 |
2010-06-03 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
１１−ベータ−ヒドロキシステロイドデヒドロゲナーゼの阻害因子としてのｎ−アドマンチルベンザミド
|
|
ZA200904916B
(en)
*
|
2007-02-23 |
2010-09-29 |
High Point Pharmaceuticals Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
CN101652359A
(zh)
*
|
2007-03-09 |
2010-02-17 |
高点制药有限责任公司 |
作为羟类固醇脱氢酶抑制剂的吲哚-和苯并咪唑酰胺类
|
|
EP2141990A4
(en)
*
|
2007-03-28 |
2011-07-06 |
High Point Pharmaceuticals Llc |
ACTIVE COMPOUNDS ON 11BETA-HSD1
|
|
JP2010526777A
(ja)
*
|
2007-04-24 |
2010-08-05 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
置換アミドの医薬用途
|
|
JP2012509879A
(ja)
*
|
2008-11-21 |
2012-04-26 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
アダマンチルベンズアミド化合物
|